In Conversation

Turkey Pharma Report 2019
Latest Reports
Turkey Pharma Report 2019
- 2019
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare system that is the envy of its neighbours – stands as one of the most promising healthcare and life science investment destinations in its region. Topics covered in this report range from the successes of Turkey’s Healthcare Transformation Programme (HTP), which has skyrocketed the level of the country’s healthcare system in little over a decade, the ongoing debate around reimbursement, and a localization policy to which multinational companies are having to adapt. Other hot-button issues touched upon include Turkey’s standing as the world’s…
Turkey Pharma Sector Industry Report
Latest Reports
Turkey Pharma Sector Industry Report
- 2016
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the Turkish pharmaceutical industry; an industry with a rich heritage currently striving to find the balance between fostering domestic growth and building stronger international partnerships. It features interviews with senior executives from the major companies in Turkey and leaders of the country’s most important institutions, updated facts and figures on Turkey’s healthcare and pharma sectors, and an exclusive in-depth cover story, ‘Navigating the Crossroads’.  
Turkey Pharma Report
Latest Reports
Turkey Pharma Report
- 2012
We use cookies to ensure that we give you the best experience on our site. For more info click here